The vasopeptidase inhibitor omapatrilat [`Vanlev'; Bristol-Myers Squibb] has been granted priority review status by Health Canada

• Book ID: 120871332
• Publisher: Adis International Limited (now part of Wolters Kluwer Health)
• Year: 2000
• Weight: 151 KB
• Volume: &NA
• Category: Article
• ISSN: 1173-8324
• DOI: 10.2165/00128413-200012240-00059